  See all
 |
Articles: Myeloproliferative Dz |
Prior Articles
The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: Applicability at the time of diagnosis and later during disease course
Blood, 01/13/09
Evidence Based Medicine
Insights into the manifestations, outcomes and mechanisms of leukemogenesis in Down syndrome
Blood, 01/13/09
Evidence Based Medicine
The CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
Blood, 01/13/09
Evidence Based Medicine
CD146+ bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis
Haematologica, 01/12/09
Free full text
Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment
European Journal of Haematology, 01/09/09 Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma
Leukemia, 01/09/09 Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases
Leukemia, 01/09/09 Insulin-like Growth Factor-1- and Interleukin-6-related Gene Variation and Risk of Multiple Myeloma
Cancer Epidemiology, Biomarkers & Prevention, 01/08/09 Phosphoinositide-phospholipase c β1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia
Journal of Clinical Oncology, 01/07/09
Evidence Based Medicine
WHIM syndrome: congenital immune deficiency disease
Current Opinion in Hematology, 01/07/09 Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens
Cancer, 01/06/09 ATM-ATR dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK cell susceptibility and is associated with a senescent phenotype
Blood, 01/06/09
Evidence Based Medicine
Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma
Experimental Hematology, 01/05/09 Expression profiling of apoptosis-related genes in megakaryocytes: BNIP3 is downregulated in primary myelofibrosis
Experimental Hematology, 01/05/09 An update on the diagnosis and management of PNH
Myeloproliferative Disorders in practice, 12/31/08 Juvenile myelomonocytic leukaemia - an update
Myeloproliferative Disorders in practice, 12/31/08 Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes
Journal of Clinical Oncology, 12/30/08
Evidence Based Medicine
Inhibition of the Bcl-XL deamidation pathway in myeloproliferative disorders
New England Journal of Medicine, 12/30/08 Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of Clinical Oncology, 12/30/08 Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders
Blood Cells, Molecules, and Diseases, 12/30/08
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
189 Available Pages
|
|
